Investment
Features
FeesSafety
Academy
More
Pluang+

Legacy Education expands into Texas with a new Central Coast College campus in Houston.

Market News
15 Sep 2026
PRNewsWire
View Source
Bullish
Legacy Education expands into Texas with a new Central Coast College campus in Houston.

Legacy Education Inc. announced it will open a new Central Coast College campus in Houston, Texas, marking its entry into the Texas market. The 28,000-square-foot facility is planned to open in the second fiscal quarter of 2027 and will offer healthcare career training programs similar to those at its California campus. This expansion targets Houston's large healthcare sector to meet growing demand for trained healthcare workers. The new campus will feature modern classrooms and labs designed for hands-on learning, supporting Legacy Education's mission to provide accessible, career-focused education.

Legacy Education's expansion into Texas is the subject here. For readers following the health sector, here is Pluang's market snapshot as of Sep 15, 2026 19:14 WIB: out of 91 priced US health stocks, 28 rose and 59 fell. Notable prices include DNA at USD 6.86 (-2.14%), TXG at USD 69.00 (-1.58%), and LLY at USD 1,155.65 (+1.57%).

More News

Ascendis Pharma gains full rights to TransCon tech, launches $400M buyback, and posts positive trial data.

Ascendis Pharma gains full rights to TransCon tech, launches $400M buyback, and posts positive trial data.

Ascendis Pharma A/S regained full control of its TransCon technology for metabolic diseases from Novo Nordisk, allowing it to independently develop and sell treatments, including for obesity. The company also authorized a $400 million share repurchas...

Market News
Bullish
4 hours ago
Deutsche Bank upgrades AstraZeneca to Hold after mixed drug trial results.

Deutsche Bank upgrades AstraZeneca to Hold after mixed drug trial results.

Deutsche Bank upgraded AstraZeneca's stock rating from Sell to Hold following mixed results from its drug trials. The lung disease drug tozorakimab showed strong Phase III results and received FDA priority review, signaling potential future growth. H...

Analyst Insights
Neutral
4 hours ago
Northrop Grumman completes full inert Sentinel ICBM assembly, advancing toward 2027 test launch.

Northrop Grumman completes full inert Sentinel ICBM assembly, advancing toward 2027 test launch.

Northrop Grumman and the U.S. Air Force successfully completed the vertical integration of a full-scale inert Sentinel intercontinental ballistic missile (ICBM) at Vandenberg Space Force Base, marking a key milestone in the missile's development. The...

Market News
Bullish
4 hours ago
MakeMyTrip remains a Buy with planned IPO and strong business diversity supporting growth

MakeMyTrip remains a Buy with planned IPO and strong business diversity supporting growth

MakeMyTrip Limited is maintained as a Buy due to its upcoming IPO of its Indian subsidiary, which could unlock value and help fund convertible redemptions. The company’s diversified business model, particularly in hotels and buses, helps offset chall...

Market News
Bullish
4 hours ago
Dave & Buster's shares drop 12% after Q2 sales miss, but signs of recovery emerge.

Dave & Buster's shares drop 12% after Q2 sales miss, but signs of recovery emerge.

Dave & Buster's stock fell 12% following a weaker-than-expected Q2 report with revenue down 2.4% and a net loss of $12.5 million. The company saw a 2.9% decline in same-store sales, driven by a 9% drop in entertainment sales, partially offset by food...

Company Fundamentals
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App